SHANGHAI, CHINA – June 29, 2022 – Eurofins DiscoverX® (Eurofins DiscoverX Products LLC), a global industry leader of products for small and large molecule drug discovery and QC lot release, today announced the official opening of its new China biotechnology office in Shanghai.
Eurofins DiscoverX Products France SAS is now the single source for all Eurofins Discovery products in Europe. We are excited to announce that Eurofins DiscoverX is optimizing its distribution channels in Europe for improved customer service and supply chain through its French company, Eurofins DiscoverX Products France SAS.
Companies will work together on critical components to accelerate client-sponsored validation programs through downstream drug development
Eurofins Announces the Completion of the Acquisition of Beacon Discovery, Inc.
Eurofins DiscoverX Extends Its Ordering Options Through Fisher Scientific Procurement
Eurofins DiscoverX announces Catalent Biologics as a North American Certified Biologics Analytical Laboratory
Eurofins DiscoverX announces partnership with VelaLabs through their Certified CRO Program for PathHunter® Bioassays that will enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions
Eurofins Acquires DiscoverX
Introducing PathHunter® iONCscan Services